Luye Pharma USA transforms outcomes in central nervous system (CNS) disorders through science and innovation.
Developing therapies for complex neurological conditions.
Luye Pharma USA’s FDA-approved long-acting injectable therapy helps address treatment adherence challenges in schizophrenia and schizoaffective disorder.
For full prescribing information, safety details, and other important information, please visit the product website.
Helping patients achieve better outcomes and quality of life.
Luye is advancing life sciences through innovation, global collaboration, and a vision for better patient care.
Get the latest updates from Luye Pharma USA as we advance innovation and support patients worldwide.
Be part of a global team working to advance treatments and improve patient outcomes.
